The Tickborne Complete 2.0 Panel evaluates immune markers associated with Lyme disease and related co-infections, helping identify hidden or previously undiagnosed infections.
This advanced testing provides a more comprehensive view than standard screening, allowing your provider to develop a targeted, personalized treatment plan for recovery and long-term health.
The Tickborne Complete 2.0 Panel evaluates immune markers associated with Lyme disease and related co-infections, helping identify hidden or previously undiagnosed infections.
This advanced testing provides a more comprehensive view than standard screening, allowing your provider to develop a targeted, personalized treatment plan for recovery and long-term health.